Short interest screen · refreshed after the Sep 28, 2026 close
Short squeeze monitor: Healthcare
Stocks with the largest share of their tradable float sold short. A high share of float sold short means many traders are betting on a decline. If the price rises instead, short sellers may need to buy shares to close their positions, which can add to the move. Days to cover shows how many average trading days that buying would take.
| # | Company | Price | Today | Short % float | Days to cover | Δ short int. | Short vol. 10d | Mkt cap |
|---|---|---|---|---|---|---|---|---|
| 51 | AVTXAvalo TherapeuticsHealthcare | $15.08 | −2.52% | 24.9% | 13.2 | +4% | 57.6% | $808.7M |
| 52 | TMDXTransMedics GroupHealthcare | $82.73 | −3.00% | 24.8% | 10.7 | −1% | 54.6% | $2.87B |
| 53 | SNDXSyndax PharmaceuticalsHealthcare | $17.86 | −1.87% | 24.5% | 14.7 | −5% | 48.2% | $1.59B |
| 54 | HROWHarrowHealthcare | $31.60 | −4.45% | 24.5% | 15.7 | +10% | 57.8% | $1.18B |
| 55 | MPLTMapLight TherapeuticsHealthcare | $10.45 | −0.10% | 24.4% | 6.1 | −4% | 63.9% | $580.8M |
| 56 | CRVSCorvus PharmaceuticalsHealthcare | $11.87 | +2.15% | 24.4% | 18.2 | −10% | 68.0% | $998.5M |
| 57 | CABACabaletta BioHealthcare | $2.00 | −3.38% | 24.4% | 5.2 | −20% | 51.5% | $339.1M |
| 58 | DERMJourney MedicalHealthcare | $6.43 | +4.72% | 24.3% | 22.5 | −1% | 38.0% | $181.5M |
| 59 | ARCTArcturus Therapeutics HoldingsHealthcare | $14.46 | +4.40% | 24.0% | 6.4 | −10% | 52.0% | $411.0M |
| 60 | CATXPerspective TherapeuticsHealthcare | $2.50 | −0.79% | 24.0% | 16.9 | −2% | 56.2% | $285.4M |
| 61 | LBRXLB PharmaceuticalsHealthcare | $37.89 | +1.50% | 23.9% | 21.5 | +6% | 58.6% | $1.22B |
| 62 | KYTXKyverna TherapeuticsHealthcare | $6.82 | +0.15% | 23.8% | 10.8 | +4% | 66.0% | $421.8M |
| 63 | PGENPrecigenHealthcare | $7.81 | +0.77% | 23.8% | 16.3 | 0% | 47.6% | $2.80B |
| 64 | EYPTEyePointHealthcare | $3.31 | −8.56% | 23.8% | 6.4 | +9% | 41.5% | $285.4M |
| 65 | ACHCAcadia HealthcareHealthcare | $27.91 | −0.64% | 23.4% | 18.8 | −5% | 71.3% | $2.60B |
| 66 | TWSTTwist BioscienceHealthcare | $179.60 | −1.77% | 23.3% | 8.9 | +4% | 44.7% | $11.91B |
| 67 | NAMSNewAmsterdam Pharma Company N.VHealthcare | $23.58 | +4.43% | 23.3% | 9.9 | +17% | 45.9% | $2.82B |
| 68 | CRSPCRISPR Therapeutics AGHealthcare | $54.09 | −0.26% | 23.1% | 16.5 | +2% | 65.7% | $5.23B |
| 69 | CRMDCorMedixHealthcare | $7.89 | +0.51% | 23.0% | 18.5 | +1% | 62.3% | $615.0M |
| 70 | STOKStoke TherapeuticsHealthcare | $25.50 | +2.82% | 22.7% | 17.3 | 0% | 63.7% | $1.65B |
| 71 | DMACDiaMedica TherapeuticsHealthcare | $8.32 | +4.79% | 22.6% | 36.7 | +2% | 66.1% | $448.7M |
| 72 | LRMRLarimar TherapeuticsHealthcare | $3.17 | +3.09% | 22.5% | 14.9 | +1% | 61.8% | $329.3M |
| 73 | SANASana BiotechnologyHealthcare | $2.93 | −0.51% | 22.5% | 12.2 | 0% | 53.8% | $877.1M |
| 74 | IOVAIovance BiotherapeuticsHealthcare | $10.99 | −0.09% | 22.4% | 7.4 | −1% | 41.4% | $4.98B |
| 75 | SLDBSolid BiosciencesHealthcare | $7.28 | −0.14% | 22.4% | 19.6 | +4% | 68.5% | $780.6M |
| 76 | CLYMClimb BioHealthcare | $11.74 | +0.69% | 22.2% | 4.5 | +17% | 60.5% | $674.3M |
| 77 | BCAXBicara TherapeuticsHealthcare | $18.80 | −2.13% | 22.1% | 22.6 | +3% | 44.4% | $1.24B |
| 78 | CADLCandel TherapeuticsHealthcare | $11.19 | +1.54% | 22.1% | 10.3 | +1% | 57.3% | $856.2M |
| 79 | NUVBNuvation BioHealthcare | $5.60 | −2.44% | 22.0% | 10.9 | +7% | 51.8% | $1.97B |
| 80 | XNCRXencorHealthcare | $25.60 | +7.56% | 21.8% | 13.2 | +6% | 61.1% | $1.90B |
| 81 | ANNXAnnexonHealthcare | $4.01 | +10.16% | 21.4% | 11.7 | +2% | 54.0% | $760.2M |
| 82 | GALTGalectin TherapeuticsHealthcare | $3.93 | +0.77% | 21.4% | 25.2 | +3% | 52.8% | $396.3M |
| 83 | VSTMVerastemHealthcare | $7.77 | +0.39% | 21.4% | 6.5 | −1% | 50.9% | $703.7M |
| 84 | SDGRSchrodingerHealthcare | $29.50 | +2.25% | 21.3% | 8.7 | +1% | 44.6% | $2.21B |
| 85 | PRLDPrelude Therapeutics IncorporatedHealthcare | $3.91 | +0.90% | 21.3% | 9.0 | +1% | 62.4% | $312.0M |
| 86 | OMDAOmada HealthHealthcare | $19.39 | −1.37% | 21.2% | 5.9 | +30% | 52.7% | $1.19B |
| 87 | IRONDisc MedicineHealthcare | $64.92 | −0.49% | 21.2% | 13.6 | −2% | 50.6% | $2.49B |
| 88 | DSGNDesign TherapeuticsHealthcare | $12.36 | +1.98% | 21.1% | 7.3 | −1% | 69.1% | $773.5M |
| 89 | QDELQuidelOrthoHealthcare | $10.83 | −1.01% | 21.1% | 10.8 | 0% | 43.7% | $742.7M |
| 90 | PVLAPalvella TherapeuticsHealthcare | $139.83 | +1.21% | 21.0% | 12.8 | +2% | 59.3% | $2.01B |
| 91 | RNAAtrium TherapeuticsHealthcare | $8.42 | +1.57% | 20.9% | 8.2 | +1% | 27.3% | $144.0M |
| 92 | SGPSpyGlass PharmaHealthcare | $25.98 | −4.03% | 20.7% | 11.6 | +12% | 60.0% | $869.0M |
| 93 | EIKNEikon TherapeuticsHealthcare | $7.91 | −0.13% | 20.5% | 9.3 | +3% | 61.7% | $428.4M |
| 94 | TGTXTG TherapeuticsHealthcare | $56.19 | −2.16% | 20.5% | 18.5 | 0% | 61.5% | $8.60B |
| 95 | RZLTRezolute, Inc. Common Stock (NV)Healthcare | $4.18 | +7.18% | 20.4% | 14.8 | −1% | 44.0% | $404.3M |
| 96 | VORVor BiopharmaHealthcare | $18.31 | −1.13% | 20.4% | 11.1 | +3% | 45.2% | $1.08B |
| 97 | PRTAProthenaHealthcare | $8.72 | +5.19% | 20.2% | 26.5 | +1% | 71.1% | $447.7M |
| 98 | IRDOpus GeneticsHealthcare | $5.05 | +6.09% | 20.2% | 1.5 | +15% | 61.4% | $420.1M |
| 99 | IMMXImmix BiopharmaHealthcare | $11.47 | +4.56% | 20.2% | 7.8 | 0% | 56.0% | $820.6M |
| 100 | GRALGRAILHealthcare | $132.63 | +4.52% | 20.2% | 12.7 | +1% | 50.5% | $5.92B |
Data guard: 9 stocks withheld — NG (reported short interest is above 100% of float); EGO (reported short interest is above 100% of float); BNS (reported short interest is above 100% of float); AQN (reported short interest is above 100% of float); CAE (reported short interest is above 100% of float); GIL (reported short interest is above 100% of float); EPRX (reported short interest is above 100% of float); MFI (reported short interest is above 100% of float); CHRN (float record is implausibly small). They return once the float record is verified.
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.